Neutrophil/lymphocyte ratio is a more sensitive systemic inflammatory response biomarker than platelet/lymphocyte ratio in the prognosis evaluation of unresectable pancreatic cancer.
about
Neutrophil/lymphocyte ratio is a more sensitive systemic inflammatory response biomarker than platelet/lymphocyte ratio in the prognosis evaluation of unresectable pancreatic cancer.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Neutrophil/lymphocyte ratio is ...... nresectable pancreatic cancer.
@en
Neutrophil/lymphocyte ratio is ...... nresectable pancreatic cancer.
@nl
type
label
Neutrophil/lymphocyte ratio is ...... nresectable pancreatic cancer.
@en
Neutrophil/lymphocyte ratio is ...... nresectable pancreatic cancer.
@nl
prefLabel
Neutrophil/lymphocyte ratio is ...... nresectable pancreatic cancer.
@en
Neutrophil/lymphocyte ratio is ...... nresectable pancreatic cancer.
@nl
P2093
P2860
P356
P1433
P1476
Neutrophil/lymphocyte ratio is ...... nresectable pancreatic cancer.
@en
P2093
Chong Zhou
Fei-Ran Gong
Meng-Yao Wu
Qiaoming Zhi
P2860
P304
88835-88844
P356
10.18632/ONCOTARGET.21340
P407
P577
2017-09-27T00:00:00Z